Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Antiviral Research|January 1, 2013
Hepatitis B e antigen levels and response to peginterferon: influence of precore and basal core promoter mutantsMilan J Sonneveld, Vincent Rijckborst, Louwerens Zwang, et al.Journal of Hepatology|January 17, 2012
Validation of a stopping rule at week 12 using HBsAg and HBV DNA for HBeAg-negative patients treated with peginterferon alfa-2aVincent Rijckborst, Bettina E Hansen, Peter Ferenci, et al.The American Journal of Gastroenterology|May 13, 2010
A randomized trial of peginterferon alpha-2a with or without ribavirin for HBeAg-negative chronic hepatitis BVincent Rijckborst, Martijn J ter Borg, Yilmaz Cakaloglu, et al.Journal of Viral Hepatitis|May 29, 2019
Hepatitis B core-related antigen monitoring during peginterferon alfa treatment for HBeAg-negative chronic hepatitis BMargo J H van Campenhout, Vincent Rijckborst, Willem Pieter Brouwer, et al.Hepatology (Baltimore, Md.)|August 5, 2010
Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levelsVincent Rijckborst, Bettina E Hansen, Yilmaz Cakaloglu, et al.European Journal of Gastroenterology & Hepatology|June 7, 2012
Long-term follow-up of hepatitis B e antigen-negative patients treated with peginterferon α-2a: progressive decrease in hepatitis B surface antigen in respondersVincent Rijckborst, Peter Ferenci, Meral Akdogan, et al.Antiviral Therapy|May 4, 2013
Baseline hepatitis B surface antigen (HBsAg) as predictor of sustained HBsAg loss in chronic hepatitis B patients treated with pegylated interferon-α2a and adefovirR Bart Takkenberg, Louis Jansen, Annikki de Niet, et al.Pageof 2